Brain cancer drug with radiation improves survival

PARIS (Reuters) - Patients using Schering-Plough Corp's Temodal along with radiation therapy after surgery for the most common and aggressive form of primary brain cancer showed prolonged survival in a recent study, the U.S. drugmaker said on Monday.

Continue to Brain cancer drug with radiation improves survival on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz